钟岚 主任医师
硕士招生类型：学术型；专业型
硕士招生专业：内科学（消化内科学）
博士招生类型：
博士招生专业：
所在院系：附属东方医院
联系方式：lanzhong83@sina.com
课题组链接：
研究方向
主要任职
科研业绩

脂肪肝 、肝纤维化及胃肠道疾病的基础和临床研究
fatty liver,liver fibrosis, chronic gastrointestinal disease





国家医学考试中心试题开发专家委员会委员
第七届上海市中西医结合学会消化系统疾病专业委员会肝病学组副组长
上海市医学会消化内镜专科分会第八届青年委员会委员
上海市医学会消化内镜专科分会第八届委员会大肠病学组委员
上海市医学会肝病学会药物性肝病学组委员
同济大学附属东方医院药物临床试验伦理委员会委员
上海交通大学炎症性肠病诊治中心秘书




主持浦东新区科技发展基金民生科研专项基金资助课题：rhBMP-9抑制SREBP-1表达减轻肥胖、高脂血症性脂肪肝的实验研究（PKJ2016-Y62），.承担并完成上海市卫生局青年基金2项，作为Sub-PI完成埃索美拉唑、莫固思达、黛力新等多项消化科药物临床试验研究。
Dr.Lan zhong was born in Shaoxing, Zhejiang province, China and attended medicalschool at Shanghai Medical University, receiving her degree in medicine in 1996.She performed research on non-alcoholic fatty liver and liver fibrosis during herpostgraduate training .
Dr. Zhong iscertified in internal medicine and in Gastroenterology in China, and in 1999started to work in the Department of Gastroenterology and Hepatology at ShanghaiEast Hospital as Staff Gastroenterologist.
As a senior medicalconsultant, Dr. Zhong actively participates in teaching medical students,residents and fellows. She was elected as “Best teachers of 2012,2013,2014 inEast Hospital”. Her clinical practice is almost exclusively in fatty liver, livercirrhosis, liver fibrosis and IBD. Besides seeing patients in the office, shealso performs upper endoscopy (EGD) and colonoscopy .
Inthe course of clinical work, she adhered to the basic and clinical studies offatty liver and gastrointestinal diseases. Untill now, she has completed 2projects which were funded by Shanghai Municipal Health Bureau, and won aproject which is funded by the Pudong New Area science and TechnologyCommission.

Selected publication in recent 4 years：
1. STK31 as novel biomarker of metastatic potentialand tumorigenicity of colorectal cancer. Oncotarget, 2017 ( the Firstauthor)
2. Cyanidin 3-glucoside(C3G) attenuatesexperimental diabetic cardiomyopathy in diabetic rats. SaudiJ Bio Sci, 2016( Epub) (the corresponding author)
3. Lentivirus-mediated knockdown of rhomboid domaincontaining 1 inhibits colorectal cancer cell growth. Mol Med Reports 2015 (the Correspondingauthor)
4. The anti-fibroticeffect of bone morphogenic protein-7(BMP-7) on liver fibrosis. Int J med Sci,10(4):441-450,2013(the First author)